NEWS
< back to news list

NanoSanguis Scientific Council: profile of prof. Tomasz Ciach

An expert in the field of nanotechnology, researcher, inventor, author of two technologies, dozens of patents and over 50 publications – this is a brief description of Prof. Dr. Hab. Eng. Tomasz Ciach, Chairman of the Scientific Council at NanoSanguis, one of the companies of the NanoGroup group.

Prof. Tomasz Ciach, as befits a scientist, can boast a rich scientific CV. He graduated with a master’s degree from two universities: in 1991 from the Warsaw University of Technology at the Faculty of Chemical Engineering, and a year later from the Faculty of Biology of the University of Warsaw. At the Warsaw University of Technology, he then obtained the titles of doctor (1998) and habilitated doctor (2010). In 2019, President Andrzej Duda presented him with a professorial nomination in the field of engineering and technical sciences.

During this time he participated in scientific internships at renowned foreign universities: the Institute of Experimental Physics in Vienna, the Lund University of Technology and the University of Helsinki. In the years 2000-2003 he was briefly associated professionally with the Delft University of Technology.

Currently, Prof. Ciach heads the Department of Biotechnology and Bioprocess Engineering at the Faculty of Chemical and Process Engineering of the Warsaw University of Technology, and is also a member of the management board of the listed company NanoGroup, and two companies that are part of the group: NanoVelos and NanoThea.

Prof. Ciach is a visionary, but also a creator of technologies, many of which have been commercialized. An example of such solutions are polymer structures based on nanofibers for the filtration of liquids and gases. This technology was developed on a mass scale by the British branch of Amazon. Other examples include: technologies for the production of coronary stents that secrete drugs, Nelaton type urinary catheters with high biocompatibility (a solution still used today by one of the Polish companies based in Bydgoszcz). In the area of bioengineering, he worked on hydroxyapatite nanoparticles, which are used in various types of medical products, polymer fillings and cosmetics. One of the technologies was licensed by the University of Technology to Biovico in Gdynia.

Currently, Prof. Ciach leads research on nanosystems used in medicine, which is the main focus of his research work. These are mainly nanoparticles and macromolecules intended for targeted delivery of drugs and nucleic acids for use in the treatment of cancer and inflammatory diseases. This work is carried out both at NanoGroup and at the Warsaw University of Technology.

Prof. Tomasz Ciach has successfully combined his research career with his professional career for many years. He is the founder of the companies NanoVelos, NanoSanguis and NanoThea, which currently form the NanoGroup capital group. These companies deal with polysaccharide nanoparticles for drug delivery for cancer treatment, oxygen carrier nanoparticles for long-term storage of human organs and polysaccharide nanoparticles containing isotopes for cancer brachytherapy.

In addition, he is involved in two other projects no longer associated with NanoGroup. These are the companies: StenoCoat, which deals with the development of coatings for medical devices, and Science4Beauty, where he acts as an investor and mentor. This company deals with the development of modern cosmetics based on scientific knowledge and the first product is already on the market.

Bibliographic data:

  • 145 scientific publications in international journals,
  • 40 domestic and foreign patents granted and more pending.


Teaching activities:

  • Supervisor of 11 doctoral theses and over 200 master’s and engineering theses.
  • Lecturer and head of the Bioengineering specialization at the Faculty of Chemical Engineering, Warsaw University of Technology.

Decorations and awards:

  • Doctoral thesis defended with distinction.
  • Gold medal at the International Exhibition of Inventions Eureka’98 in Brussels.
  • Special Prize of the Association of Hungarian Inventors “Genius” 1998.
  • Award of the Rector of the Warsaw University of Technology for scientific achievements 1999.
  • Award of the Rector of the Warsaw University of Technology for scientific achievements 2002.
  • “NOT” Team Award, 2nd degree, Master of Technology, Warsaw 2002.
  • Award of the Rector of Warsaw University of Technology, 1st degree, for scientific achievements in 2011.
  • Sendzimir Gold Medal, Polish Association of Inventors, 2015.
  • Luminatus Bloomberg Businessweek Team Award, for BioMedLab in my hands, 2016.
  • Award for special achievements of the Rector of the Medical University of Warsaw, 2017.
  • Honorary Pearl of the Polish Economy in the Science category, presented by Prof. M. Kleiber, 2017.
  • Medal of the KEN (National Education Commission) 2018.
  • Award of the Rector of Warsaw University of Technology named after Prof. Ignacy Mościcki for the implementation of technology, 2018.
  • Award and medal of the Prime Minister of the Republic of Poland for achievements in the field of invention, presented by the President of the Patent Office of the Republic of Poland, 2019.
  • WUT Rector’s Award for Scientific Achievements 2021.
Copyright © NanoGroup 2024

Prof. Tomasz Ciach

Founder, Member of the Management Board of NANOGROUP S.A.

Nanotechnology expert. Professor at the Faculty of Chemical and Processing Engineering, Warsaw University of Technology, head of the Biotechnology and Bioprocessing Division. Author of two technologies that are already in production stage, 12 granted patents and over 50 publications. Founder of BioMedLab research group, consultant in numerous companies (AstraZeneca, Procter and Gamble, Reckit, Adamed, Balton, Galmed). Work on various aspects of Biomedical Engineering, mostly on biomedical nanotechnology, active coatings for medical implants, nanoparticles for cancer treatment, biodegradable and nonbiodegradable implants, bone and vascular prosthesis. He gives rare, but already brilliant example of how brave ideas become socially and financially valuable.

Piotr Mierzejewski

Vice President of the Management Board of NANOGROUP S.A.

Clinical pharmacology specialist, former advisor to the Minister of Health on drug policy. He negotiated Poland’s accession to the EU in the field of pharmacy, responsible for the implementation of EU directives in the field of pharmacy into the Polish legal system. Co-founder of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Owner of a consulting company cooperating with international pharmaceutical companies in the field of introducing new technologies to the Polish market.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.